1
|
Kuzikov AV, Masamrekh RA, Filippova TA, Tumilovich AM, Strushkevich NV, Gilep AA, Khudoklinova YY, Shumyantseva VV. Bielectrode Strategy for Determination of CYP2E1 Catalytic Activity: Electrodes with Bactosomes and Voltammetric Determination of 6-Hydroxychlorzoxazone. Biomedicines 2024; 12:152. [PMID: 38255257 PMCID: PMC10812958 DOI: 10.3390/biomedicines12010152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 12/26/2023] [Accepted: 01/05/2024] [Indexed: 01/24/2024] Open
Abstract
We describe a bielectrode system for evaluation of the electrocatalytic activity of cytochrome P450 2E1 (CYP2E1) towards chlorzoxazone. One electrode of the system was employed to immobilize Bactosomes with human CYP2E1, cytochrome P450 reductase (CPR), and cytochrome b5 (cyt b5). The second electrode was used to quantify CYP2E1-produced 6-hydroxychlorzoxazone by its direct electrochemical oxidation, registered using square-wave voltammetry. Using this system, we determined the steady-state kinetic parameters of chlorzoxazone hydroxylation by CYP2E1 of Bactosomes immobilized on the electrode: the maximal reaction rate (Vmax) was 1.64 ± 0.08 min-1, and the Michaelis constant (KM) was 78 ± 9 μM. We studied the electrochemical characteristics of immobilized Bactosomes and have revealed that electron transfer from the electrode occurs both to the flavin prosthetic groups of CPR and the heme iron ions of CYP2E1 and cyt b5. Additionally, it has been demonstrated that CPR has the capacity to activate CYP2E1 electrocatalytic activity towards chlorzoxazone, likely through intermolecular electron transfer from the electrochemically reduced form of CPR to the CYP2E1 heme iron ion.
Collapse
Affiliation(s)
- Alexey V. Kuzikov
- Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119121 Moscow, Russia; (R.A.M.); (T.A.F.); (A.A.G.); (V.V.S.)
- Department of Biochemistry, Faculty of Biomedicine, Pirogov Russian National Research Medical University, 1, Ostrovityanova Street, 117997 Moscow, Russia;
| | - Rami A. Masamrekh
- Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119121 Moscow, Russia; (R.A.M.); (T.A.F.); (A.A.G.); (V.V.S.)
- Department of Biochemistry, Faculty of Biomedicine, Pirogov Russian National Research Medical University, 1, Ostrovityanova Street, 117997 Moscow, Russia;
| | - Tatiana A. Filippova
- Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119121 Moscow, Russia; (R.A.M.); (T.A.F.); (A.A.G.); (V.V.S.)
- Department of Biochemistry, Faculty of Biomedicine, Pirogov Russian National Research Medical University, 1, Ostrovityanova Street, 117997 Moscow, Russia;
| | - Anastasiya M. Tumilovich
- Institute of Bioorganic Chemistry NASB, 5 Building 2, V.F. Kuprevich Street, 220084 Minsk, Belarus; (A.M.T.); (N.V.S.)
| | - Natallia V. Strushkevich
- Institute of Bioorganic Chemistry NASB, 5 Building 2, V.F. Kuprevich Street, 220084 Minsk, Belarus; (A.M.T.); (N.V.S.)
| | - Andrei A. Gilep
- Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119121 Moscow, Russia; (R.A.M.); (T.A.F.); (A.A.G.); (V.V.S.)
- Institute of Bioorganic Chemistry NASB, 5 Building 2, V.F. Kuprevich Street, 220084 Minsk, Belarus; (A.M.T.); (N.V.S.)
| | - Yulia Yu. Khudoklinova
- Department of Biochemistry, Faculty of Biomedicine, Pirogov Russian National Research Medical University, 1, Ostrovityanova Street, 117997 Moscow, Russia;
| | - Victoria V. Shumyantseva
- Institute of Biomedical Chemistry, 10, Pogodinskaya Street, 119121 Moscow, Russia; (R.A.M.); (T.A.F.); (A.A.G.); (V.V.S.)
- Department of Biochemistry, Faculty of Biomedicine, Pirogov Russian National Research Medical University, 1, Ostrovityanova Street, 117997 Moscow, Russia;
| |
Collapse
|
2
|
Shu T, Wang J, Li X, Wang X, Wang S. Cytochrome P450 2D6 biosensor for perphenazine based on multi-walled carbon nanotube/ionic liquid and tetrathiafulvalene-tetracyanoquinodimethane salt/ionic liquid gels. Electrochim Acta 2022. [DOI: 10.1016/j.electacta.2022.141656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
|
3
|
Shumyantseva VV, Koroleva PI, Bulko TV, Sergeev GV, Usanov SA. Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions. Drug Metab Pers Ther 2021; 37:241-248. [PMID: 34860476 DOI: 10.1515/dmpt-2021-0116] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 08/31/2021] [Indexed: 12/29/2022]
Abstract
OBJECTIVES Human cytochrome P450 3A4 is the most abundant hepatic and intestinal Phase I enzyme that metabolizes approximately 60% marketed drugs. Simultaneous administration of several drugs may result in appearance of drug-drug interaction. Due to the great interest in the combination therapy, the exploration of the role of drug as "perpetrator" or "victim" is important task in pharmacology. In this work the model systems based on electrochemically driven cytochrome P450 3A4 for the analysis of drug combinations was used. We have shown that the analysis of electrochemical parameters of cytochrome P450 3A4 and especially, potential of the start of catalysis, Eonset, possess predictive properties in the determination of the leading ("perpetrator") properties of drug. Based on these experimental data, we concluded, that the more positive potential of the start of catalysis, Eonset, the more pronounced the role of drug as leading medication. METHODS Electrochemically driven cytochrome P450 3A4 was used as probe and measuring tool for the estimation of the role of interacting drugs. RESULTS It is shown that the electrochemical non-invasive model systems for monitoring the catalytic activity of cytochrome P450 3A4 can be used as prognostic devise in assessment of drug/drug interacting medications. CONCLUSIONS Cytochrome P450 3A4 activity was studied in electrochemically driven system. Method was implemented to monitor drug/drug interactions. Based on the obtained experimental data, we can conclude that electrochemical parameter such as potential of onset of catalysis, Eonset, has predictive efficiency in assessment of drug/drug interacting medications in the case of the co-administration.
Collapse
Affiliation(s)
- Victoria V Shumyantseva
- Institute of Biomedical Chemistry, Moscow, Russia.,Pirogov Russian National Research Medical University, Moscow, Russia
| | | | | | | | | |
Collapse
|
4
|
Shumyantseva VV, Makhova AA, Shikh EV, Bulko TV, Kuzikov AV, Masamrekh RA, Shkel T, Usanov S, Gilep A, Archakov AI. Bioelectrochemical Systems as Technologies for Studying Drug Interactions Related to Cytochrome P450. BIONANOSCIENCE 2018. [DOI: 10.1007/s12668-018-0567-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
5
|
Aliakbarinodehi N, De Micheli G, Carrara S. Enzymatic and Nonenzymatic Electrochemical Interaction of Abiraterone (Antiprostate Cancer Drug) with Multiwalled Carbon Nanotube Bioelectrodes. Anal Chem 2016; 88:9347-9350. [PMID: 27626107 PMCID: PMC5125716 DOI: 10.1021/acs.analchem.6b02747] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Unexplored electrochemical behavior of abiraterone, a recent and widely used prostate cancer drug, in interaction with cytochrome P450 3A4 (CYP3A4) enzyme and multiwalled carbon nanotubes (MWCNTs) is investigated in this work. The results reported in this work are significant for personalized medicine and point-of-care chemical treatment, especially to improve the life expectancy and quality of life of patients with prostate-cancer. To this purpose, enzymatic and nonenzymatic electrochemical biosensors were developed and characterized with different concentrations of abiraterone. Nonenzymatic biosensors were functionalized with MWCNTs as a catalyst for signal enhancement, while enzymatic biosensors have been obtained with CYP3A4 protein immobilized on MWCNTs as recognition biomolecule. Enzymatic electrochemical experiments demonstrated an inhibition effect on the CYP3A4, clearly observed as a diminished electrocatalytic activity of the enzyme. Electrochemical responses of nonenzymatic biosensors clearly demonstrated the direct electroactivity of abiraterone when reacting with MWCNT as well as an electrode-fouling effect.
Collapse
Affiliation(s)
- Nima Aliakbarinodehi
- Integrated Systems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland 1015
| | - Giovanni De Micheli
- Integrated Systems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland 1015
| | - Sandro Carrara
- Integrated Systems Laboratory, École Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland 1015
| |
Collapse
|